Synthesis, Labeling and Preclinical Evaluation of a Squaric Acid Containing PSMA Inhibitor Labeled with


Journal

ChemMedChem
ISSN: 1860-7187
Titre abrégé: ChemMedChem
Pays: Germany
ID NLM: 101259013

Informations de publication

Date de publication:
20 04 2020
Historique:
received: 03 10 2019
revised: 19 12 2019
pubmed: 15 2 2020
medline: 21 5 2021
entrez: 15 2 2020
Statut: ppublish

Résumé

The L-lysine urea-L-glutamate (KuE) represents a key motif in recent diagnostic and therapeutic radiopharmaceuticals targeting the prostate specific membrane antigen (PSMA). Using a squaric acid moiety for coupling of KuE with a radioactive label, the squaric acid as a linker in the PSMA ligand seems to mimic the aromatic structure of the naphthylalanine unit on PSMA-617. In this work, we investigate the influence of squaric acid moiety on the biological activity of the compound carrying a KuE motif and three typical chelates. The derivatives TRAM.SA.KuE, DOTAGA.SA.KuE and NODAGA.SA.KuE were all synthesized in straightforward organic reactions and purified by HPLC afterward. Different amounts of tracer were labeled at different temperatures with

Identifiants

pubmed: 32057189
doi: 10.1002/cmdc.201900559
doi:

Substances chimiques

Cyclobutanes 0
Dipeptides 0
Gallium Isotopes 0
Gallium Radioisotopes 0
Heterocyclic Compounds, 1-Ring 0
Oligopeptides 0
PSMA-617 0
Radiopharmaceuticals 0
gallium 68 PSMA-11 0
Edetic Acid 9G34HU7RV0
Prostate-Specific Antigen EC 3.4.21.77
squaric acid SVR9D0VODW

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

695-704

Informations de copyright

© 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Références

L. A. Torre, R. L. Siegel, Cancer J Clin 2015, 65, 87-108.
A. Afshar-Oromieh, A. Malcer, J Nucl Med Mol Imaging 2013, 40, 486-495.
P. J. Davidson, D. van den Ouden, Eur. Urol. 1996, 29, 168-173.
M. R. A. Pillai, R. Nanabala, Nucl. Med. Biol. 2016, 43, 692-720.
D. A. Silver, I. Pellicer, Cli Cancer Res 1997, 3, 81-85.
S. Perner, M. D. Hofer, Hum. Pathol. 2007, 38, 696-701.
J.-M. Mosquera, S. Perner, I Pathol 2007, 212, 91-101.
C. Barinka, C. Rojas, Curr. Med. Chem. 2012, 19, 856-870.
T. Wüstermann, U. Bauder-Wüst, Theranostics 2016, 6, 1085-1095.
A. X. Zhang, R. P. Murelli, J. Am. Chem. Soc. 2010, 132, 12711-12716.
S. Lütje, S. Heskamp, Theranostics 2015, 1388-1401.
E. Witkowska-Patena, A. Mazurek, Cent European J Urol 2017, 70, 37-43.
A. P. Kozikowski, J. Zhang, J. Med. Chem. 2004, 47, 1729-1738.
M. Eder, M. Schäfer, Bioconjugate Chem. 2012, 23, 668-697.
R. Ian Store, C. Aciro, Chem. Soc. Rev. 2011, 40, 2330-2346.
E. Neuse, B. Green, Justus Liebigs Ann. Chem. 1973, 1973, 619-632.
F. R. Wurm, H.-A. Klok, Chem. Soc. Rev. 2013, 42, 8220-8236.
L. F. Tietze, M. Arlt, Chem. Ber. 1991, 124, 1215-1221.
D. Quinonero, A. Frontera, Tetrahedron Lett. 2000, 41, 2001-2005.
B. Davis, J. Chem. Soc. 1999, 1, 3215-3237.
D. P. Gamblin, E. M. Scanlan, Chem. Rev. 2016, 109, 131-163.
S. E. Rudd, P. Roselt, Chem. Commun. 2016, 52, 11889-11892.
S. Yoganathan, C. S. Sit, Org. Biomol. Chem., 2011, 9, 2133-2141.
K. Sato, K. Seio, J. Am. Chem. Soc. 2002, 124, 12715-12724.
A. Rostami, A. Colin, J. Org. Chem. 2010, 75, 3983-3992.
C. W. Lee, K. Ichiyama, Bioorg. Med. Chem. Lett. 2005, 15, 4243-4246.
J. Gauger, G. Manecke, Chem. Ber. 1970, 103, 3553-3562.
M. Eder, M. Schäfer, Bioconjugate Chem. 2012, 23, 688-697.
J. Cardinale, M. Schäfer, J. Nucl. Med. 2015, 58, 425-431.
M. Benesova, M. Schäfer, J. Nucl. Med. 2015, 56, 914-920.
A. Afshar-Oromiehm, A. Malcher, Eur. J. Nucl. Med. Mol. Imaging 2013, 40, 486-495.
M. Benesova, U. Bauder-Wüst, J. Med. Chem. 2016, 59, 1761-1775.
M. Benesova, M. Schäfer, J. Nucl. Med. 2015, 56, 914-920.
K. P. Zhernosekov, D. V. Filosofov, J. Nucl. Med. 2007, 48, 1741-1748.
M. Asti, G. Pietri, Nucl. Med. Biol. 2018, 35, 721-724.

Auteurs

Lukas Greifenstein (L)

Institute of Nuclear Chemistry, Johannes Gutenberg University, Fritz-Strassmann-Weg 2, 55128, Mainz, Germany.

Nils Engelbogen (N)

Institute of Nuclear Chemistry, Johannes Gutenberg University, Fritz-Strassmann-Weg 2, 55128, Mainz, Germany.

Hanane Lahnif (H)

Institute of Nuclear Chemistry, Johannes Gutenberg University, Fritz-Strassmann-Weg 2, 55128, Mainz, Germany.

Jean-Philippe Sinnes (JP)

Institute of Nuclear Chemistry, Johannes Gutenberg University, Fritz-Strassmann-Weg 2, 55128, Mainz, Germany.

Ralf Bergmann (R)

Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden Rossendorf, Bautzner Landstraße 400, 01328, Dresden, Germany.
Department of Biophysics and Radiation Biology, Semmelweis University, Tűzoltó u. 37-47, 1094, Budapest, Hungary.

Michael Bachmann (M)

Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden Rossendorf, Bautzner Landstraße 400, 01328, Dresden, Germany.

Frank Rösch (F)

Institute of Nuclear Chemistry, Johannes Gutenberg University, Fritz-Strassmann-Weg 2, 55128, Mainz, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH